<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Diabetes and Metabolic Disorders</JournalTitle><Volume>1</Volume><Issue>1</Issue></Journal><ArticleTitle>ANTINOCICEPTIVE EFFECT OF BACLOFEN IN ALLOXAN-INDUCED DIABETIC MICE.</ArticleTitle><FirstPage>51</FirstPage><LastPage>57</LastPage><AuthorList><Author><FirstName>Hossein</FirstName><LastName>Hosseinzadeh</LastName></Author><Author><FirstName>Farid</FirstName><LastName>Ilami</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>05</Day></PubDate></History><Abstract>Objective: To evaluate the effect of hyperglycemia on the antinociceptive activity of baclofen, a GABAB agonist, in mice.
methods: We examined the antinociceptive effect of baclofen (2.5-7.5mg/kg injected intraperitoneally) in alloxan-induced mice using the hot-plate and tail-flick tests, both thermal tests.
results: Baclofen produced a dose-dependent inhibition of hot-plate response in both normoglycemic and diabetic mice. The antinociceptive activity of baclofen was slightly reduced in diabetic mice. In comparison, the antinociceptive activity of morphine (10mg/kg), used as control, was significantly reduced in diabetic mice.
conclusion: Our results show that hyperglycemia reduces the antinociceptive action of baclofen less than it does that of morphine.</Abstract><web_url>https://jdmd.tums.ac.ir/index.php/jdmd/article/view/16</web_url></Article></Articles>
